Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: www.sri.com/case-studies/synfini/
Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: www.sri.com/case-studies/synfini/
A cherished SRI colleague and globally respected leader in education research, Mary Wagner leaves behind an extraordinary legacy of groundbreaking work supporting children and youth with disabilities and their families.
A global health leader is exploring how SRI’s robotic telemanipulation technology can enhance pharmaceutical manufacturing.
Researchers have developed a new framework that reduces generative AI hallucinations by up to 32%.